Bollard Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-42
Closed -$6K 610
2023
Q2
$6K Buy
+42
New +$6.74K ﹤0.01% 375
2022
Q2
Sell
-423
Closed -$80K 382
2022
Q1
$80K Hold
423
﹤0.01% 302
2021
Q4
$112K Hold
423
﹤0.01% 278
2021
Q3
$122K Hold
423
﹤0.01% 268
2021
Q2
$84K Hold
423
﹤0.01% 302
2021
Q1
$82K Sell
423
-300
-41% -$61.5K ﹤0.01% 297
2020
Q4
$139K Buy
723
+300
+71% +$54.6K 0.01% 232
2020
Q3
$62K Hold
423
﹤0.01% 305
2020
Q2
$52K Buy
+423
New +$49.8K ﹤0.01% 339

Other funds holding RGEN

Bollard Group's RGEN Position: Q3 2023 in Review

Bollard Group sold out of Repligen (RGEN) in Q3 2023, closing a stake of 42 shares — an estimated $6K sold.

Bollard Group first reported a position in RGEN in Q2 2020 and held it in 9 quarters. The position peaked at $139K in Q4 2020. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Bollard Group reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Bollard Group sold 42 Repligen shares in Q3 2023, an estimated $6K.
  • Bollard Group first reported a position in Repligen in Q2 2020 and held it in 9 quarters.
  • Bollard Group's Repligen position peaked at $139K in Q4 2020.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.